Overige protocollen

Children with Neuroblastoma                                                        MRD Monitoring in NBL

Children with cancer, ≤18 years, treated in the PMC with             MIFI
intensive chemotherapy (i.e. patients of who is to be
expected that profound neutropenia occurs)

A prospective observational study of patients aged                      PINOCCHIO
0-17 years who will receive various, intravenously
administered, classes of chemotherapeutic agents used
in children with several subtypes of cancer as standard
of care to study the population PK of those agents.